Professional Experience
- Current roles: Consultant Medical Oncologist and Research Lead, Gynaecology Unit, The Royal Marsden; Professor of Women’s Cancers at ICR.
- Joined as Consultant in 2011 after completing oncology training.
- Leadership: Lead investigator or co-investigator in many national and international clinical trials in gynaecological cancers.
- Theme Lead (Cancer Treatment Effects 2022–2027) for the NIHR ICR/RM Biomedical Research Centre.
- Has supervised MD(Res) and PhD fellows; leads collaborations with genomic, pharmacology and translational research groups.
Academic Contributions
- Teaching and mentorship: Supervises research fellows, mentors junior oncologists and clinicians interested in gynaecological cancer research.
- Conference leadership: Co-Chair or track chair roles at European Society for Medical Oncology (ESMO) and ESMO Asia.
- Committee membership: EORTC Executive Steering Committee for Gynaecological Cancers, ESMO Women for Oncology Committee, Chair of ESMO Resilience Task Force, GCIG Rare Cancers Committee.
- Trial and translational research: Driving biomarker-guided therapies, rare tumour studies, combination novel agent trials.
Areas of Expertise
- Ovarian cancer — first-line, recurrent disease, novel combinations.
- Advanced endometrial cancer — systemic therapy and targeted approaches.
- Cervical cancer — systemic management, recurrence settings.
- Rare gynaecological cancers and histologies — addressing unmet needs in rare tumour subtypes.
- Biomarker-driven therapy selection, precision oncology: use of PARP inhibitors and targeted agents guided by molecular markers.
- Design and conduct of early-phase clinical trials, translational research integration.
Publications and Research
Professor Banerjee has authored over 175 peer-reviewed publications in high-impact journals including New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology, and Annals of Oncology.
Examples of recent work:
- “Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation” — examined long-term breast cancer outcomes in women with prior ovarian cancer and BRCA mutation.
- “Physician knowledge, use, and perceptions of genetic biomarker testing for the management of patients with newly diagnosed advanced ovarian cancer” — explored how oncologists apply biomarker testing in practice.
- “Ovarian clear cell carcinoma (OCCC) subtype immunological and molecular features in trial settings” — research into rare ovarian cancer response to immunotherapies.
She plays leading roles in many national and international trials as UK and global Chief Investigator, and is co-chair of the Gynecological Cancer InterGroup Rare Cancers Committee.
Patient Care Philosophy
- “I am driven by the needs of my patients and my dedication to improving the treatment of gynecological cancers.” — Prof. Susana Banerjee
- Priority on clear communication and patient education: she explains treatments, trials, risks and benefits in accessible language.
- Empathy and individualized care: she personalizes treatment plans based on patient values, comorbidities and molecular profile.
- International reach: offers face-to-face, video or telephone consultations via Royal Marsden Private Care across Chelsea, Cavendish Square and Sutton.
- Focus on innovation and access: strongly supports trial enrollment, giving patients options for novel therapies when standard ones have limited efficacy.
Professional Affiliations
- Member / leader in European Society for Medical Oncology (ESMO); former Director of Membership; Chair of ESMO Resilience Task Force.
- European Organization for Research and Treatment of Cancer (EORTC) — served on Executive Steering Committee for Gynaecological Cancers.
- Co-Chair, Gynecological Cancer InterGroup (GCIG) Rare Cancers Committee.
- Member, European Society of Gynaecological Oncology (ESGO) Scientific Committee.
- President, Royal Society of Medicine Oncology Section.
- General Medical Council (GMC, UK) Registration.
FAQs
- Is Professor Susana Banerjee board-certified?
- Yes. She is FRCP (Fellow of the Royal College of Physicians) in the UK and holds full consultant medical oncology certification.
- What types of cancers does she treat?
- She treats ovarian cancer (primary and recurrent), advanced endometrial cancer, cervical cancer, and rarer gynaecological cancers.
- Does she accept international patients?
- Yes. She offers face-to-face, video and telephone consultations via Royal Marsden Private Care locations in London.
- What is the typical hospital stay or treatment duration?
- Stay and duration depend on treatment. Many are outpatient or day-case; some require inpatient care depending on side effects or complex regimens.
- What languages does she speak?
- She practices in the UK and communicates fluently in English.
- How many clinical trials has she led?
- She serves as UK and Global Chief Investigator for over 30 national and international clinical trials.
- How can I schedule a consultation with her?
- You can book via The Royal Marsden Private Care (Chelsea, Sutton, Cavendish Square) or request a video/telephone consultation.
